These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27816502)

  • 1. Dysregulated corticostriatal activity in open-field behavior and the head-twitch response induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine.
    Rangel-Barajas C; Estrada-Sánchez AM; Barton SJ; Luedtke RR; Rebec GV
    Neuropharmacology; 2017 Feb; 113(Pt A):502-510. PubMed ID: 27816502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of mutant huntingtin in cortical efferents improves behavioral inflexibility and corticostriatal dynamics in Huntington's disease mice.
    Estrada-Sánchez AM; Blake CL; Barton SJ; Howe AG; Rebec GV
    J Neurophysiol; 2019 Dec; 122(6):2621-2629. PubMed ID: 31693428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model.
    Canal CE; Morgan D
    Drug Test Anal; 2012; 4(7-8):556-76. PubMed ID: 22517680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of adenosine(1) (A(1)) receptors suppresses head shakes induced by a serotonergic hallucinogen in rats.
    Marek GJ
    Neuropharmacology; 2009 Jun; 56(8):1082-7. PubMed ID: 19324062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-acetylcysteine modulates hallucinogenic 5-HT(2A) receptor agonist-mediated responses: behavioral, molecular, and electrophysiological studies.
    Lee MY; Chiang CC; Chiu HY; Chan MH; Chen HH
    Neuropharmacology; 2014 Jun; 81():215-23. PubMed ID: 24534112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the sigma-1 receptor selective compound LS-1-137 on the DOI-induced head twitch response in mice.
    Malik M; Rangel-Barajas C; Mach RH; Luedtke RR
    Pharmacol Biochem Behav; 2016 Sep; 148():136-44. PubMed ID: 27397487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice.
    Egashira N; Shirakawa A; Okuno R; Mishima K; Iwasaki K; Oishi R; Fujiwara M
    Pharmacol Biochem Behav; 2011 Jul; 99(1):52-8. PubMed ID: 21504759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional behavioral modulation of corticostriatal communication in the R6/2 mouse model of Huntington's disease.
    Hong SL; Cossyleon D; Hussain WA; Walker LJ; Barton SJ; Rebec GV
    PLoS One; 2012; 7(10):e47026. PubMed ID: 23056565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysregulated Neuronal Activity Patterns Implicate Corticostriatal Circuit Dysfunction in Multiple Rodent Models of Huntington's Disease.
    Miller BR; Walker AG; Barton SJ; Rebec GV
    Front Syst Neurosci; 2011; 5():26. PubMed ID: 21629717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes inhibits the DOI-induced head-twitch response in mice.
    Miyata S; Hirano S; Kamei J
    Psychopharmacology (Berl); 2004 Dec; 177(1-2):224-9. PubMed ID: 15290007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anandamide inhibits the DOI-induced head-twitch response in mice.
    Egashira N; Mishima K; Uchida T; Hasebe N; Nagai H; Mizuki A; Iwasaki K; Ishii H; Nishimura R; Shoyama Y; Fujiwara M
    Psychopharmacology (Berl); 2004 Feb; 171(4):382-9. PubMed ID: 14586538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the head-twitch response induced by hallucinogens in mice: detection of the behavior based on the dynamics of head movement.
    Halberstadt AL; Geyer MA
    Psychopharmacology (Berl); 2013 Jun; 227(4):727-39. PubMed ID: 23407781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological modulation of abnormal involuntary DOI-induced head twitch response movements in male DBA/2J mice: II. Effects of D3 dopamine receptor selective compounds.
    Rangel-Barajas C; Malik M; Mach RH; Luedtke RR
    Neuropharmacology; 2015 Jun; 93():179-90. PubMed ID: 25698528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerance and cross-tolerance to head twitch behavior elicited by phenethylamine- and tryptamine-derived hallucinogens in mice.
    Smith DA; Bailey JM; Williams D; Fantegrossi WE
    J Pharmacol Exp Ther; 2014 Dec; 351(3):485-91. PubMed ID: 25271256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in senescence-accelerated mice.
    Niimi K; Takahashi E; Itakura C
    Exp Anim; 2010; 59(4):441-7. PubMed ID: 20660990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.
    Egashira N; Iwasaki K; Ishibashi A; Hayakawa K; Okuno R; Abe M; Uchida N; Mishima K; Takasaki K; Nishimura R; Oishi R; Fujiwara M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1516-20. PubMed ID: 18558456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological modulation of abnormal involuntary DOI-induced head twitch response in male DBA/2J mice: I. Effects of D2/D3 and D2 dopamine receptor selective compounds.
    Rangel-Barajas C; Malik M; Vangveravong S; Mach RH; Luedtke RR
    Neuropharmacology; 2014 Aug; 83():18-27. PubMed ID: 24680675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine Modifies Corticostriatal Plasticity and Amphetamine Rewarding Behaviors in Mice(1,2,3).
    Storey GP; Gonzalez-Fernandez G; Bamford IJ; Hur M; McKinley JW; Heimbigner L; Minasyan A; Walwyn WM; Bamford NS
    eNeuro; 2016; 3(1):. PubMed ID: 26866057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LSD and the phenethylamine hallucinogen DOI are potent partial agonists at 5-HT2A receptors on interneurons in rat piriform cortex.
    Marek GJ; Aghajanian GK
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1373-82. PubMed ID: 8819525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hallucinogen DOI reduces low-frequency oscillations in rat prefrontal cortex: reversal by antipsychotic drugs.
    Celada P; Puig MV; Díaz-Mataix L; Artigas F
    Biol Psychiatry; 2008 Sep; 64(5):392-400. PubMed ID: 18436196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.